Artiva Biotherapeutics, Inc. (ARTV) Form 8-K — Nov 17, 2026
Artiva Biotherapeutics disclosed that director Elizabeth Hougen resigned from its board effective November 11, 2026. The company stated her resignation was not due to any disagreement over operations, policies, or practices.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.